InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
0.8200
0.00 (0.00%)
At close: May 15, 2026, 4:00 PM EDT
0.9299
+0.1099 (13.40%)
After-hours: May 15, 2026, 7:46 PM EDT
InterCure Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for InterCure in the last 12 months.
Price Target: n/a
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for InterCure.
Recommendation Trends
| Rating | Nov '22 | Dec '22 | Jan '23 | Feb '23 | Mar '23 | Apr '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 0 |
| Buy | 3 | 3 | 3 | 3 | 3 | 0 |
| Hold | 4 | 4 | 4 | 4 | 4 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $10 → $5 | Buy | Maintains | $10 → $5 | +509.76% | Apr 12, 2023 |
| Barclays | Barclays | Hold Initiates $40 | Hold | Initiates | $40 | +4,778.05% | Dec 11, 2017 |
| Credit Suisse | Credit Suisse | Buy Maintains $68 → $54 | Buy | Maintains | $68 → $54 | +6,485.37% | Nov 14, 2017 |
| Keybanc | Keybanc | Buy Maintains $68 → $46 | Buy | Maintains | $68 → $46 | +5,509.76% | Nov 13, 2017 |
| Baird | Baird | Buy Maintains $67 → $46 | Buy | Maintains | $67 → $46 | +5,509.76% | Nov 10, 2017 |
Financial Forecast
Revenue This Year
574.00M
from 270.20M
Increased by 112.44%
Revenue Next Year
n/a
from 574.00M
EPS This Year
1.70
from -0.66
EPS Next Year
n/a
from 1.70
Financial currency is ILS. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 |
|---|---|
| High | 590.9M |
| Avg | 574.0M |
| Low | 551.5M |
Revenue Growth
| Revenue Growth | 2026 |
|---|---|
| High | 118.7% |
| Avg | 112.4% |
| Low | 104.1% |
EPS Forecast
| EPS | 2026 |
|---|---|
| High | 1.75 |
| Avg | 1.70 |
| Low | 1.64 |
EPS Growth
| EPS Growth | 2026 |
|---|---|
| High | - |
| Avg | - |
| Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.